drugset
drugset / Trial / NCT01176981

Outpatient Administration of High Dose Methotrexate (HD MTX) in Patients With Osteosarcoma

NCT01176981 ↗

Phase 3 Completed 6 enrolled The Hospital for Sick Children
NaSingle-groupOpen-labelTreatment

Summary

The primary purpose of this study is to determine the safety and feasibility of delivering HDMTX in an outpatient setting.

Timeline

Start
2010-10
Primary completion
2012-10
Completion
2012-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Methotrexate Small molecule 12 g Intravenous

Indications

osteosarcoma